Uroporphyrinogen Decarboxylase
EstablishedUROD deficiency causes porphyria cutanea tarda, the most common porphyria, often triggered by acquired factors.
This enzyme deficiency causes the most common type of porphyria, leading to fragile, blistering skin in sun-exposed areas. Unlike some other porphyrias, this one is often triggered by things like alcohol, certain hormones, or an iron overload problem, rather than being purely inherited — so treatment often focuses on removing those triggers.
Uroporphyrinogen decarboxylase (UROD) is an enzyme in the heme synthesis pathway; its deficiency causes porphyria cutanea tarda (PCT), the most common type of porphyria, characterized by sun-triggered blistering skin lesions.
Low UROD enzyme activity supports PCT diagnosis in a patient with blistering, fragile skin on sun-exposed areas, though PCT is often acquired or triggered rather than purely inherited, distinguishing it from the acute porphyrias like the one involving porphobilinogen deaminase discussed earlier.
Diagnosed via a combination of urine/plasma porphyrin pattern testing and enzyme activity assay; unlike acute intermittent porphyria, PCT deficiency is frequently triggered or worsened by acquired factors such as alcohol use, estrogen therapy, hepatitis C infection, or iron overload rather than resulting from inherited deficiency alone.
Treatment focuses on addressing triggering factors (stopping alcohol, treating hepatitis C, managing iron overload) combined with therapeutic phlebotomy to reduce iron levels, which indirectly improves UROD enzyme function; low-dose antimalarial drugs (hydroxychloroquine) are also used in some cases.
Frequently acquired/triggered (alcohol, estrogen, hepatitis C, iron overload) rather than purely inherited.
- General hematology/dermatology reference literature on porphyria cutanea tarda diagnosis and management.